Peptide Side Effects Explained
How adverse-event profiles are reported in the peptide literature, and how to read them critically.
Last updated: 2 April 2026
How adverse events get reported
In approved-medicine trials, adverse events are systematically catalogued. In research-peptide literature, adverse-event reporting is far less consistent.
Absence of reported adverse events is not the same as absence of risk.
Common signal classes
GLP-1 receptor agonists: predominantly gastrointestinal events.
GH-axis peptides: water retention, joint discomfort, glucose changes.
Melanocortin peptides: nausea, flushing, blood pressure changes, pigmentation effects.